1. Home
  2. NLOP vs QSI Comparison

NLOP vs QSI Comparison

Compare NLOP & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NLOP

Net Lease Office Properties of Beneficial Interest

HOLD

Current Price

$11.31

Market Cap

176.7M

Sector

N/A

ML Signal

HOLD

Logo Quantum-Si Incorporated

QSI

Quantum-Si Incorporated

HOLD

Current Price

$0.85

Market Cap

191.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NLOP
QSI
Founded
N/A
2013
Country
United States
United States
Employees
N/A
145
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
176.7M
191.6M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
NLOP
QSI
Price
$11.31
$0.85
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$1.00
AVG Volume (30 Days)
110.2K
6.2M
Earning Date
05-19-2026
05-07-2026
Dividend Yield
52.20%
N/A
EPS Growth
N/A
N/A
EPS
1.69
N/A
Revenue
$118,915,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$618.07
P/E Ratio
$6.78
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.24
$0.69
52 Week High
$34.53
$3.10

Technical Indicators

Market Signals
Indicator
NLOP
QSI
Relative Strength Index (RSI) 30.68 37.88
Support Level N/A $0.69
Resistance Level $12.26 $1.08
Average True Range (ATR) 0.30 0.09
MACD -0.02 -0.03
Stochastic Oscillator 5.10 0.04

Price Performance

Historical Comparison
NLOP
QSI

About NLOP Net Lease Office Properties of Beneficial Interest

Net Lease Office Properties is a Maryland real estate investment trust that, together with its consolidated subsidiaries, owns, operates, and finances a diversified portfolio of office properties mainly leased to corporate tenants on a single-tenant, net-lease basis. The company operates as a single operating and reportable segment focused on owning and managing office properties that generate revenue mainly from long-term lease agreements with tenants.

About QSI Quantum-Si Incorporated

Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.

Share on Social Networks: